Preparing the Country for the Alzheimer’s Epidemic: A View from Science, Business, Government, and Caregivers

Part 4:  A View from Government

Date:  November 14, 2006

Location:  Washington, DC

Andrew C. von Eschenbach, MD, Acting Commissioner of the U.S. Food and Drug Administration described a model for accelerating the development of therapies across the continuum of discovery, development, and delivery, with a particular focus on the ‘molecular metamorphosis’. Such a model promises not only broad changes, but a rapid acceleration in progress.  watch video >>